Sebastian Meltzer

15PUBLICATIONS

49CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical virologyDeep learning

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 20, 2026

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

|May 20, 2026

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

|Feb 23, 2026

Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.

Anne Hansen Ree, Paula A Bousquet, Tina Visnovska

|Feb 10, 2026

Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Oct 19, 2025

Low b-values in apparent diffusion coefficient calculations overestimate diffusion in rectal cancer.

Johanna A Hundvin, Marius Bornstein, Anne Negård

|Apr 27, 2025

Serum metabolite levels identify incipient metastatic progression of rectal cancer.

Kine M Bakke, Paula A Bousquet, Sebastian Meltzer

Pageof 3

Frequent Collaborators

14 joint publications

Anne Hansen Ree

Kathrine Røe Redalen

Anne Negård

Kine M Bakke

Halfdan Sorbye

Paula Anna Bousquet

Anniken Jørlo Fuglestad

2 joint publications

Kjersti Flatmark

1 joint publications

François Ghiringhelli

1 joint publications

Kjell-Inge Gjesdal

Frequent Collaborators

14 joint publications

Anne Hansen Ree

6 joint publications

Kathrine Røe Redalen

4 joint publications

Anne Negård

2 joint publications

Kine M Bakke